None listed
Conditions
Interventions
Intervention1: SMARThealth Extend: Screening of high risk factors for CVD and referal for medium and high risk respondents to health system facility.
Control Intervention1: Usual care: In the control
Sponsors
George Institute for Global Health Australia
Eligibility
Inclusion criteria
Inclusion criteria: participants between 40-85 years
Exclusion criteria
Exclusion criteria: Respondents where measurements for blood pressure, height and weight not possible i.e. incapacitated respondents
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Indonesia: Difference in the change in the proportion from baseline to end-of-study of high risk individuals prescribed appropriate preventive medications between the intervention and control arms. India: Difference in the proportion of high risk individuals prescribed appropriate preventive medications between the screening phase (identified by ASHA) and end of the study evaluation (among those identified as high risk by ASHA during screening)Timepoint: By February 2018 | — |
Secondary
| Measure | Time frame |
|---|---|
| Indonesia: Diff in the change in the proportion from baseline to end-of-study (EOS) of high risk individuals (HRI) achieving SBP less than 140mmHg between the int and cont arms. Diff in mean reduction in BP levels between the int and cont arms. % of HRI correctly referred and followed-up by NPHWs in the intervention arm. India: % HRI correctly referred by NPHWs to PHC doctors % HRI receiving follow-up visits by NPHWs % HRI achieving blood pressure targetsTimepoint: By February 2018 | — |
Countries
India, Indonesia
Contacts
Public ContactDr Mohan Pushpinder Singh Kohli
George Institute for Global Health India
Outcome results
None listed